AIM ImmunoTech Announces Closing of its Rights Offering

OCALA, Fla., March 06, 2026 (GLOBE NEWSWIRE) -- AIM ImmunoTech Inc. (NYSE American: AIM) – AIM ImmunoTech Inc. (“AIM” or the “Company”), an immuno-pharma company focused on the ...

Early report Major update Updated Mar 7, 2026, 12:00 AM UTC

Track this event Edit in app More event pages

What changed

Early report surfaced from GlobeNewswire Public Companies 4h ago.

First seen Mar 7, 2026, 12:00 AM UTC Latest source Mar 7, 2026, 12:00 AM UTC

Update 1 4h ago

AIM ImmunoTech Announces Closing of its Rights Offering

GlobeNewswire Public Companies •published Mar 7, 2026, 12:00 AM UTC •fetched Mar 7, 2026, 12:21 AM UTC